Genetic Testing for Early Detection of Individuals at Risk of Coronary Heart Disease and Monitoring Response to Therapy: Challenges and Promises
Authors:
- H. Robert SuperkoHSH. Robert Superko
- Robert RobertsRRRobert Roberts
- Arthur AgatstonAAArthur Agatston
- Stephen FrohweinSFStephen Frohwein
- Jason S. ReingoldJRJason S. Reingold
- Thomas J. WhiteTWThomas J. White
- John J. SninskyJSJohn J. Sninsky
- Basil MargolisBMBasil Margolis
- Kathryn M. MomaryKMKathryn M. Momary
- Brenda C. GarrettBGBrenda C. Garrett
- Spencer B. KingSKSpencer B. King
Open Access
- 10 August 2011
- journal article
- review article
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 13 (5) , 396-404
Abstract
Coronary heart disease (CHD) often presents suddenly with little warning. Traditional risk factors are inadequate to identify the asymptomatic high-risk individuals. Early identification of patients with subclinical coronary artery disease using noninvasive imaging modalities would allow the early adoption of aggressive preventative interventions. Currently, it is impractical to screen the entire population with noninvasive coronary imaging tools. The use of relatively simple and inexpensive genetic markers of increased CHD risk can identify a population subgroup in which benefit of atherosclerotic imaging modalities would be increased despite nominal cost and radiation exposure. Additionally, genetic markers are fixed and need only be measured once in a patient’s lifetime, can help guide therapy selection, and may be of utility in family counseling.Keywords
This publication has 63 references indexed in Scilit:
- No Impact of KIF6 Genotype on Vascular Risk and Statin Response Among 18,348 Randomized Patients in the Heart Protection StudyJACC, 2011
- Large-scale association analysis identifies 13 new susceptibility loci for coronary artery diseaseNature Genetics, 2011
- 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling responseNature, 2011
- Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studiesThe Lancet, 2011
- KIF6 Polymorphism as a Predictor of Risk of Coronary Events and of Clinical Event Reduction by Statin TherapyThe American Journal of Cardiology, 2010
- Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapyAtherosclerosis, 2009
- Coronary Artery Calcification Compared With Carotid Intima-Media Thickness in the Prediction of Cardiovascular Disease IncidenceThe Multi-Ethnic Study of Atherosclerosis (MESA)Archives of internal medicine (1960), 2008
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data releaseThe Lancet Neurology, 2007
- Initial sequencing and analysis of the human genomeNature, 2001